Saccharomyces Boulardii Supplement - Probiotic for Gastrointestinal Health
Saccharomyces boulardii is a non-pathogenic probiotic yeast produced by a patented process which enables it to survive gastric acidity and resist proteolysis, now available to buy in supplement capsules at Supersmart. The optimal temperature for its proliferation is around 30ºC and it can quickly reach a high concentration in the gastrointestinal tract - an ideal breeding ground - where it remains at a constant concentration in its viable form. It is neither damaged nor inhibited by antibiotics and does not upset the natural balance of intestinal flora.
What are the benefits associated with Saccharomyces boulardii?
Saccaromyces boulardii acts as temporary flora to protect and maintain healthy function of the gastrointestinal tract:
- It works with the body to restore microflora.
- It produces lactic acid and B vitamins in the intestines and displaces problematic yeast species.
- It is eliminated within a few days once supplementation is stopped.
What do studies say about Saccharomyces boulardii?
Saccaromyces boulardii has been used in Europe for years to treat diarrhoea:
- Clinical trials have shown that it effectively prevents and treats diarrhoea resulting from anti biotherapy.
- Diarrhoea is the most common side effect of enteral nutrition. Studies show that adding Saccaromyces boulardii to nutritional solutions as a preventive measure halved the incidence of digestive problems.
- Other studies suggest that it supports intestinal function in a number of situations, including food allergies, Crohn's disease, traveller's diarrhoea, HIV-associated diarrhoea, and the presence of parasites, salmonella, Candida or Pseudomonas.
- Clinical trials have demonstrated the protective effect of Saccaromyces boulardii in intestinal infections including cholera and Clostridium difficile.
What are Saccaromyces boulardii mechanisms of action?
Physiological studies in cell cultures, animal models and humans have highlighted the various mechanisms of action by which Saccaromyces boulardii eradicates pathogenic agents, inhibits toxins and restores the absorption capacity of the small intestine's mucosa. They include:
- Competitive inhibition for adhesion sites.
- Inhibitory effects on toxin-induced secretions.
- Inhibition of binding to receptors by toxins.
- Immunological effects.
- Stimulation of the intestine's immune response.
- Trophic effects on intestinal mucosa.
- Release of polyamine.
Buy Saccaromyces Boulardii capsules today to benefit from its protective action.
|Daily serving: 4 capsules
Number of servings per bottle: 25
| Saccharomyces boulardii (probiotic yeast standardised to contain 2 x 1010 colony-forming units per gram
||1 000 mg
|Other ingredients: acacia gum, white rice bran.
Each vegetarian capsule contains 250 mg Saccaromyces boulardii.
LYNSIDE® Pro SCB - Lynside® Pro SCB is a Saccharomyces cerevisiae var.boulardii yeast strain (CNCM I-3799).
Directions for use
Take two vegetarian capsules twice a day, in the case of antibiotic treatment, travel to a tropical country or acute diarrhoea.
Store at temperature between 2 and 8 ° C in a dry place away from light.
Value for money
waarom zou ik?
bon produit pour palier au désordre intestinal
- Isolauri E, Kirjavainen PV, Salminen S (2002). Probiotics: a role in the treatment of intestinal infection and inflammation? Gut, 50: 54-59
- Blehaut H, Massot J, Elmer GW, Levy RH (1989). Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharm Drug Dispo, 10: 353-64.
- Fietto JL, Araújo RS, Valadão FN, Fietto LG, Brandão RL, Neves MJ, Gomes FC, Nicoli JR, Castro IM (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50(8): 615-21
- Collignon A, Sandré C, Barc MC (2010) [Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment]. Gastroenterol Clin Biol 34 Suppl 1: S71-8
- McFarland LV (2010) Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 16: 2202–2222
- Czerucka D, Piche T, Rampal P (2007) Review article: yeast as probiotics -- Saccharomyces boulardii. Aliment Pharmacol Ther 26(6): 767-78